APT SATELLITE (01045) announces annual performance, with a net profit attributable to shareholders of HK$141 million, a decrease of 31.1% year-on-year.

19:58 19/03/2026

Asia Pacific Satellite (01045) released its performance for the year 2025, the company achieved revenue of 739 million Hong Kong dollars, a decrease of 5.81% year-on-year; the net profit attributable to shareholders was 141 million Hong Kong dollars, a decrease of 31.1% year-on-year; basic earnings per share were 15.23 Hong Kong cents; proposed final dividend of 6 Hong Kong cents per share.

APT Satellite (01045) announced its financial performance for the year 2025. The company achieved a revenue of HK$739 million, a decrease of 5.81% compared to the previous year. The net profit attributable to shareholders was HK$141 million, a decrease of 31.1% year-on-year. The basic earnings per share were 15.23 HK cents. The company plans to distribute a final dividend of 6 HK cents per share. The announcement stated that the decrease in revenue was mainly due to a reduction in income from satellite transponder capacity provided during the year.

CHINA HONGBAO(08316): Liu Huiqing appointed as independent non-executive director.

CHINARES PHARMA(03320): Dong-E-E-Jiao's net profit attributable to shareholders in 2025 is estimated to be approximately 1.739 billion yuan, an increase of 11.66% year-on-year.

Hong Kong-listed AI medical stock buys back the first share! YIDU TECH (02158) repurchased nearly 15 million Hong Kong dollars on March 19, deepening regional layout with Guangxi Medical University.

CHINA HONGBAO(08316): Liu Huiqing appointed as independent non-executive director.

CHINARES PHARMA(03320): Dong-E-E-Jiao's net profit attributable to shareholders in 2025 is estimated to be approximately 1.739 billion yuan, an increase of 11.66% year-on-year.

Hong Kong-listed AI medical stock buys back the first share! YIDU TECH (02158) repurchased nearly 15 million Hong Kong dollars on March 19, deepening regional layout with Guangxi Medical University.